Misonix, Inc., a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, announced today that it will present at the ROTH Capital 23rd Annual Growth Stock Conference on Tuesday, March 15, 2011 at the Ritz Carlton Hotel, Dana Point, CA.
41333
Misonix to present at the ROTH Capital Growth Stock conference on March 15, 2011
42103
Dynogen goes public via reverse merger
134956
UCB : acquires Lectus Therapeutics'' key pharmaceutical assets
108482
Regulatory, commercial considerations are the primary drivers for biosimilar development
4311
Mid-market companies look to expand
150609
The global spinal surgical market is projected to reach almost $6.5 billion by 2015
158277
MicroPhage raises $11 million
28181
Medical technology industry is strong contributor to US economy
13842
BD to present at investor healthcare conferences
162431
Sirtris Pharmaceuticals presents at American chemical Society April 7
55456
Matt Roth to see specialist
156825
Ducommun declares dividend
140704
Amgen licenses molecule for the treatment of chronic and neuropathic pain to Ortho-McNeil-Janssen Pharmaceuticals, Inc.
123998
TSMC joins Sematech
12617
Alchemia to spin off oncology business
79208
Nasdaq warns Oncothyreon;
105472
ResMed Inc. to present at upcoming conferences